ASCOT: a tale of two treatment regimens

BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7523.1022-b (Published 27 October 2005) Cite this as: BMJ 2005;331:1022

Odds are that it's hype

  1. Martin G Duerden, general practitioner (martin@theduerdens.co.uk)
  1. Meddygfa Gyffin, Conwy LL32 8LT

    EDITOR—The editorial on ASCOT seems to back hype rather than evidence based medicine.1 The 2004 update of the British Hypertension Society's guideline recommends first line use of angiotensin modifying drugs in non-black people younger than 55,apparently on the basis of a study with 56 patients that looked at blood pressure response.2 The contemporaneous recommendations from the National Institutefor Health and Clinical …

    View Full Text

    Sign in

    Log in through your institution